When will Sotoracib (AMG510) be launched in the country?
Doctors and scientists have known for decades that harmful mutations in a gene called KRAS are the root cause of cancer in thousands of people. For many years, KRAS was considered an “immovable” goal. In 2021year5month, the Food and Drug Administration(FDA)accelerated the approval of the firstKRASblocking drug sotorasiib. This approval is a major breakthrough in the entire field.
Under the new approval, sotoraxib can be used to treat non-small cell lung cancer that has spread to nearby ( locally advanced ) or distant (metastatic ) (NSCLC)Patients who have previously received at least one other systemic cancer treatment, such as chemotherapy, must have a specific KRAS mutation in their tumor, called G12C . Sotoraxib has promising results in the treatment of cancer.
Sotoracib (AMG510)It is not currently on the market in China, but SotoracibAMG510 has started clinical trials in China. The trial was designed to evaluate the safety and tolerability of sotoraxib as well as its pharmacokinetics and clinical activity in patients in China. It can be seen that the domestic launch time of sotorasibu remains to be further confirmed. But the domestic launch is just around the corner, which is also good news for patients.
Sotorasibu is divided into original drugs and generic drugs. The original drug is available in Hong Kong and costs approximately 4 more than a month’s supply. There are officially marketed versions of generic drugs in Laos and Bangladesh, which cost about 1 to 20000 a month. Different versions have different prices, and patients can choose drugs according to their actual conditions. The retail price of Everest Pharmaceuticals in Bangladesh120mg56tablets4 is more than a thousand, the retail price of Ziska Pharmaceuticals in Bangladesh120mg56tablets3The retail price of Element Pharmaceuticals in Laos is more than a thousand, and the retail price of Element Pharmaceuticals in Laos is 120mg56 tablets 4. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.
xa0
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)